The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Vanda Pharmaceuticals Inc. before investing. In this article, we go over a few ...

Get the detailed quarterly/annual income statement for Vanda Pharmaceuticals Inc. (VNDA). Find out the revenue, expenses and profit or loss over the last fiscal year.

DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Targeted Value Portfolio 444.72k Jul 31, 2025 0.75% 3,201,955 DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio 402.02k Jul 31, 2025 0.68% ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...